New Developments in Hypertensive Encephalopathy.
Recommended Citation
Miller JB, Suchdev K, Jayaprakash N, Hrabec D, Sood A, Sharma S, and Levy PD. New developments in hypertensive encephalopathy. Curr Hypertens Rep 2018; 20(2):13.
Document Type
Article
Publication Date
2-26-2018
Publication Title
Current hypertension reports
Abstract
PURPOSE OF REVIEW: This review summarizes the latest science on hypertensive encephalopathy and posterior reversible encephalopathy syndrome (PRES). We review the epidemiology and pathophysiology of these overlapping syndromes and discuss best practices for diagnosis and management.
RECENT FINDINGS: Diagnosis of hypertensive encephalopathy largely relies on exclusion of other neurological emergencies. We review the extensive causes of PRES and its imaging characteristics. Management strategies have not changed substantially in the past decade, though newer calcium channel blockers simplify the approach to blood pressure reduction. While this alone may be sufficient for treatment of hypertensive encephalopathy in most cases, management of PRES also depends on modification of other precipitating factors. Hypertensive encephalopathy and PRES are overlapping disorders for which intensive blood pressure lowering is critical. Further research is indicated to both in diagnosis and additional management strategies for these critical conditions.
Medical Subject Headings
Antihypertensive Agents; Blood Pressure; Brain; Humans; Hypertension; Hypertensive Encephalopathy
PubMed ID
29480370
Volume
20
Issue
2
First Page
13
Last Page
13
